2020. Rivaroxaban versus Warfarin for Prevention of Thromboembolism in Bangladeshi Patients with Non-Valvular Atrial Fibrillation. University Heart Journal. 16, 2 (Oct. 2020), 99–105. DOI:https://doi.org/10.3329/uhj.v16i2.49666.